Dr. Martens Management

Management criteria checks 3/4

Dr. Martens' CEO is Kenny Wilson, appointed in Jul 2018, has a tenure of 4.92 years. total yearly compensation is £773.00K, comprised of 93.3% salary and 6.7% bonuses, including company stock and options. directly owns 1.12% of the company’s shares, worth MX$312.89M. The average tenure of the management team and the board of directors is 3.5 years and 2.4 years respectively.

Key information

Kenny Wilson

Chief executive officer

UK£773.0k

Total compensation

CEO salary percentage93.3%
CEO tenure4.9yrs
CEO ownership1.1%
Management average tenure3.5yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Kenny Wilson's remuneration changed compared to Dr. Martens's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023UK£773kUK£721k

UK£129m

Dec 31 2022n/an/a

UK£153m

Sep 30 2022n/an/a

UK£177m

Jun 30 2022n/an/a

UK£179m

Mar 31 2022UK£2mUK£700k

UK£181m

Dec 31 2021n/an/a

UK£118m

Sep 30 2021n/an/a

UK£54m

Jun 30 2021n/an/a

UK£44m

Mar 31 2021UK£815kUK£118k

UK£35m

Compensation vs Market: Kenny's total compensation ($USD977.03K) is about average for companies of similar size in the MX market ($USD872.09K).

Compensation vs Earnings: Kenny's compensation has been consistent with company performance over the past year.


CEO

Kenny Wilson (56 yo)

4.9yrs

Tenure

UK£773,000

Compensation

Mr. Kenneth Wilson, also known as Kenny, is Chief Executive Officer at Dr. Martens Limited and Dr. Martens plc since July 2018 and serves as its Director since January 5, 2021. He joined Dr. Martens Limite...


Leadership Team

NamePositionTenureCompensationOwnership
Kenneth Wilson
CEO & Director4.9yrsUK£773.00k1.12%
MX$ 312.9m
Jon Mortimore
CFO & Director7.2yrsUK£503.00k0.64%
MX$ 177.8m
Geert Peeters
Chief Operating Officer5yrsno datano data
Ronald Garricks
Chief Information Officer3.2yrsno datano data
Emily Reichwald
General Counsel & Company Secretary8.2yrsno datano data
Meg Johnson
Chief Marketing Officer1.2yrsno datano data
Sue Gannon
Chief Human Resources Officer2yrsno datano data
Lorenzo Moretti
President of EMEA3.2yrsno datano data
Sean O'Neill
Chief Digital Officer5.2yrsno datano data
Derek Chan
President of APAC3.8yrsno datano data
Adam Meek
Chief Product Officer1.5yrsno datano data
Jennifer Somer
President of Americas1.6yrsno datano data

3.5yrs

Average Tenure

Experienced Management: DOCS N's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kenneth Wilson
CEO & Director2.4yrsUK£773.00k1.12%
MX$ 312.9m
Jon Mortimore
CFO & Director2.4yrsUK£503.00k0.64%
MX$ 177.8m
Andrew Harrison
Independent Non-Executive Directorless than a yearno datano data
Ian Rogers
Independent Non-Executive Director2.4yrsUK£67.00k0.0020%
MX$ 566.5k
Robyn Perriss
Independent Non-Executive Director2.4yrsUK£94.00k0.0099%
MX$ 2.8m
Tara Alhadeff
Representative Non-Executive Director8.1yrsno datano data
Lynne Weedall
Senior Independent Non-Executive Director2.4yrsUK£99.00k0.0021%
MX$ 586.0k
Ije Nwokorie
Independent Non-Executive Director2.4yrsUK£67.00k0.00054%
MX$ 150.7k
Paul Mason
Chair of the Board7.8yrsUK£335.00k0.79%
MX$ 219.6m

2.4yrs

Average Tenure

54yo

Average Age

Experienced Board: DOCS N's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/14 05:07
End of Day Share Price 2023/03/17 00:00
Earnings2023/03/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Martens plc is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard TaylorBarclays
David RouxBofA Global Research
Louise SinglehurstGoldman Sachs